IT Solutions
Molecular marker could predict tumor progression
Jan 24 2012
A team of scientists from the University of California, San Francisco (UCSF) have developed a method that can predict tumour progression by tracking a molecular marker in tissue samples.
The molecular marker has been linked with better survival rates, and closely monitoring the marker could provide a more effective way for doctors to track their patients' recovery after surgery. This can determine how aggressive the follow-up treatment will be.
The chemical, called 2-HG, is linked to mutations in a gene known as IDH1, which is common in low-grade tumours and linked with higher survival rates. It has been found that over 70 per cent of patients with low-grade gliomas have mutations to the IDH1 genes in their cancer cells.
The technique has not yet been optimised for every-day use in the clinic, although it provides useful insights for doctors to gauge cancer recurrence.
According to Sarah Nelson, PhD, of the Department of Radiology and Biomedical Imaging, the study will now move to "developing methods to obtain images in a clinical setting".
Posted by Neil Clark
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 25 2024 Istanbul, Turkey
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA